skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Middle Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Kudo, Masatoshi ; Finn, Richard S ; Qin, Shukui ; Han, Kwang-Hyub ; Ikeda, Kenji ; Piscaglia, Fabio ; Baron, Ari ; Park, Joong-Won ; Han, Guohong ; Jassem, Jacek ; Blanc, Jean Frederic ; Vogel, Arndt ; Komov, Dmitry ; Evans, T R Jeffry ; Lopez, Carlos ; Dutcus, Corina ; Guo, Matthew ; Saito, Kenichi ; Kraljevic, Silvija ; Tamai, Toshiyuki ; Ren, Min ; Cheng, Ann-Lii

The Lancet (British edition), 2018-03, Vol.391 (10126), p.1163-1173 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma
SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma

Zhu, Andrew X ; Rosmorduc, Olivier ; Evans, T R Jeffry ; Ross, Paul J ; Santoro, Armando ; Carrilho, Flair Jose ; Bruix, Jordi ; Qin, Shukui ; Thuluvath, Paul J ; Llovet, Josep M ; Leberre, Marie-Aude ; Jensen, Markus ; Meinhardt, Gerold ; Kang, Yoon-Koo

Journal of clinical oncology, 2015-02, Vol.33 (6), p.559-566 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

Carvajal, Richard D ; Piperno-Neumann, Sophie ; Kapiteijn, Ellen ; Chapman, Paul B ; Frank, Stephen ; Joshua, Anthony M ; Piulats, Josep M ; Wolter, Pascal ; Cocquyt, Veronique ; Chmielowski, Bartosz ; Evans, T R Jeffry ; Gastaud, Lauris ; Linette, Gerald ; Berking, Carola ; Schachter, Jacob ; Rodrigues, Manuel J ; Shoushtari, Alexander N ; Clemett, Delyth ; Ghiorghiu, Dana ; Mariani, Gabriella ; Spratt, Shirley ; Lovick, Susan ; Barker, Peter ; Kilgour, Elaine ; Lai, Zhongwu ; Schwartz, Gary K ; Nathan, Paul

Journal of clinical oncology, 2018-04, Vol.36 (12), p.1232-1239 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
4
Graphic Warning Labels Elicit Affective and Thoughtful Responses from Smokers: Results of a Randomized Clinical Trial
Graphic Warning Labels Elicit Affective and Thoughtful Responses from Smokers: Results of a Randomized Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Graphic Warning Labels Elicit Affective and Thoughtful Responses from Smokers: Results of a Randomized Clinical Trial

Evans, Abigail T ; Peters, Ellen ; Strasser, Andrew A ; Emery, Lydia F ; Sheerin, Kaitlin M ; Romer, Daniel Matsuo, Keitaro

PloS one, 2015-12, Vol.10 (12), p.e0142879 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
5
A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors
A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors

Puzanov, Igor ; Lindsay, Colin R ; Goff, Laura ; Sosman, Jeff ; Gilbert, Jill ; Berlin, Jordan ; Poondru, Srinivasu ; Simantov, Ronit ; Gedrich, Rich ; Stephens, Andrew ; Chan, Emily ; Evans, T R Jeffry

Clinical cancer research, 2015-02, Vol.21 (4), p.701-711 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
6
MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

JAMIESON, Nigel B ; MORRAN, Douglas C ; MORTON, Jennifer P ; ALI, Asif ; DICKSON, Euan J ; ROSS CARTER, C ; SANSOM, Owen J ; EVANS, T. R. Jeffry ; MCKAY, Colin J ; OIEN, Karin A

Clinical cancer research, 2012-01, Vol.18 (2), p.534-545 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
7
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial

Meyer, Tim ; Fox, Richard ; Ma, Yuk Ting ; Ross, Paul J ; James, Martin W ; Sturgess, Richard ; Stubbs, Clive ; Stocken, Deborah D ; Wall, Lucy ; Watkinson, Anthony ; Hacking, Nigel ; Evans, T R Jeffry ; Collins, Peter ; Hubner, Richard A ; Cunningham, David ; Primrose, John Neil ; Johnson, Philip J ; Palmer, Daniel H

The lancet. Gastroenterology & hepatology, 2017-08, Vol.2 (8), p.565-575 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Sem texto completo

Citações Citado por
8
Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity
Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity

POPLIN, Elizabeth ; WASAN, Harpreet ; ORMANNS, Steffen ; HEINEMANN, Volker ; BASSI, Claudio ; EVANS, T. R. Jeffrey ; ANDERSSON, Roland ; HEJIN HAHN ; PICOZZI, Vince ; DICKER, Adam ; MANN, Elaina ; VOONG, Cynthia ; ROLFE, Lindsey ; KAUR, Paramjit ; ISAACSON, Jeff ; ALLEN, Andrew ; RAPONI, Mitch ; IKDAHL, Tone ; BONDARENKO, Ihor ; DAVIDENKO, Irina ; BONDAR, Volodymyr ; GARIN, August ; BOECK, Stefan

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4453-4461 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours

Evans, T R Jeffry ; Dean, Emma ; Molife, L Rhoda ; Lopez, Juanita ; Ranson, Malcolm ; El-Khouly, Fatima ; Zubairi, Ishtiaq ; Savulsky, Claudio ; Reyderman, Larisa ; Jia, Yan ; Sweeting, Lorna ; Greystoke, Alastair ; Barriuso, Jorge ; Kristeleit, Rebecca

British journal of cancer, 2019-02, Vol.120 (4), p.379-386 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors

Soria, J.C. ; Gan, H.K. ; Blagden, S.P. ; Plummer, R. ; Arkenau, H.T. ; Ranson, M. ; Evans, T.R.J. ; Zalcman, G. ; Bahleda, R. ; Hollebecque, A. ; Lemech, C. ; Dean, E. ; Brown, J. ; Gibson, D. ; Peddareddigari, V. ; Murray, S. ; Nebot, N. ; Mazumdar, J. ; Swartz, L. ; Auger, K.R. ; Fleming, R.A. ; Singh, R. ; Millward, M.

Annals of oncology, 2016-12, Vol.27 (12), p.2268-2274 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (9.880)
  2. Revistas revisadas por pares (10.476)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (11.409)
  2. magazinearticle  (21)
  3. Anais de Congresso  (2)
  4. Book Chapters  (1)
  5. Mais opções open sub menu

Assunto 

  1. Humans  (11.432)
  2. Science & Technology  (9.567)
  3. Female  (9.535)
  4. Life Sciences & Biomedicine  (9.343)
  5. Male  (9.104)
  6. Adult  (7.902)
  7. Aged  (6.692)
  8. Biological And Medical Sciences  (3.772)
  9. Medical Sciences  (3.542)
  10. Adolescent  (2.421)
  11. Aged, 80 And Over  (2.254)
  12. Young Adult  (1.536)
  13. Risk Factors  (1.522)
  14. Treatment Outcome  (1.333)
  15. Surgery  (1.314)
  16. Retrospective Studies  (1.279)
  17. Oncology  (1.195)
  18. General & Internal Medicine  (1.150)
  19. Prospective Studies  (1.074)
  20. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1976  (399)
  2. 1976Até1987  (1.010)
  3. 1988Até1999  (2.030)
  4. 2000Até2012  (3.882)
  5. Após 2012  (4.116)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (11.393)
  2. Japonês  (1.584)
  3. Francês  (32)
  4. Português  (12)
  5. Alemão  (6)
  6. Italiano  (5)
  7. Norueguês  (5)
  8. Russo  (3)
  9. Chinês  (3)
  10. Espanhol  (3)
  11. Sueco  (1)
  12. Croatian  (1)
  13. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.